Evidence map›Paper›PMID 23280397›Full record

ArticleMolecular immunology2013

G-protein signaling modulator-3, a gene linked to autoimmune diseases, regulates monocyte function and its deficiency protects from inflammatory arthritis.

Patrick M Giguère, Matthew J Billard, Geneviève Laroche, Brian K Buckley, Roman G Timoshchenko, Marcus W McGinnis, Denise Esserman, Oded Foreman, Peng Liu, David P Siderovski and 1 more

Abstract read
In one paragraph

Article in Molecular immunology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Regulation of Chemokine Signal Integration by Activator of G-Protein Signaling 4 (AGS4).The Journal of pharmacology and experimental therapeutics · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Regulation of RGS5 GAP activity by GPSM3.Molecular and cellular biochemistry · 2015
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Patrick M GiguèreDepartment of Pharmacology, UNC School of Medicine, Chapel Hill, NC 27599-7365, USA.
Matthew J Billard
Geneviève Laroche
Brian K Buckley
Roman G Timoshchenko
Marcus W McGinnis
Denise Esserman
Oded Foreman
Peng Liu
David P Siderovski
Teresa K Tarrant

Funding

UNC CLINICAL AND TRANSLATIONAL SCIENCE AWARD: BPCAUL1RR025747 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2008 to 2011
$44.6M
UNC Clinical and Translational Science AwardUL1TR000083 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2012 to 2013
$11.6M
Differential regulation of autoimmune arthritis by monocyte subsetsR01AR063132 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LIU, PENG · 2012 to 2016
$1.6M
Structural Determinants of Heterotrimeric G-protein Nucleotide CyclingR01GM082892 · NIGMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SIDEROVSKI, DAVID P. · 2008 to 2011
$924k
G protein-coupled receptor kinase 3 regulation of leukocyte function in inflammatR03AR059286 · NIAMS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI TARRANT, TERESA KATHLEEN · 2011 to 2013
$218k
NCATS NIH HHS UL1 TR000083NCATS NIH HHS UL1TR000083NCRR NIH HHS UL1 RR025747NCRR NIH HHS UL1RR025747NIAMS NIH HHS R01 AR063132NIAMS NIH HHS R03 AR059286NIGMS NIH HHS R01 GM082892
6 · The paper itself

Abstract

Polymorphism at the GPSM3 gene locus is inversely associated with four systemic autoimmune diseases, including rheumatoid arthritis and ankylosing spondylitis. G-protein signaling modulator-3 (GPSM3) expression is most pronounced in myeloid cells, in which it targets heterotrimeric G-protein Gαi subunits of chemokine receptors, critical to immune function. To begin to explore the regulatory role of GPSM3 in monocytes, human THP-1 and primary mouse myeloid cells were cultured under stimulus conditions; GPSM3 was found by immunoblotting to be expressed at highest levels in the mature monocyte. To evaluate the effects of GPSM3 deficiency on a myeloid-dependent autoimmune disease, collagen antibody-induced arthritis (CAIA) was induced in Gpsm3-/- and control mice, which were then analyzed for clinical score, paw swelling, intra-articular proinflammatory markers, and histopathology. Mice lacking GPSM3 were protected from CAIA, and expression of monocyte-representative pro-inflammatory chemokine receptors and cytokines in paws of Gpsm3-/- mice were decreased. Flow cytometry, apoptosis, and transwell chemotaxis experiments were conducted to further characterize the effect of GPSM3 deficiency on survival and chemokine responsiveness of monocytes. GPSM3-deficient myeloid cells had reduced migration ex vivo to CCL2, CX3CL1, and chemerin and enhanced apoptosis in vitro. Our results suggest that GPSM3 is an important regulator of monocyte function involving mechanisms of differentiation, survival, and chemotaxis, and deficiency in GPSM3 expression is protective in acute inflammatory arthritis.

Indexed as

AnimalsArthritis, ExperimentalAutoimmune DiseasesCell SurvivalCytokinesDisease Models, AnimalGuanine Nucleotide Dissociation InhibitorsInflammation MediatorsMiceMice, KnockoutMonocytesMyeloid CellsReceptors, ChemokineCytokinesG18 protein, mouseGuanine Nucleotide Dissociation InhibitorsInflammation MediatorsReceptors, Chemokine

Identifiers

PMID23280397
PMCPMC3563835

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.